A Phase 2a Study to Evaluate Orally Administered ALS-008176 in Adults Hospitalized With a Respiratory Syncytial Virus
Public ClinicalTrials.gov record NCT02673476. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2a, Randomized, Double-blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Orally Administered ALS-008176 in Adults Hospitalized With a Respiratory Syncytial Virus-Related Illness
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study is being to see how effective and safe ALS-008176 is in treating adults in the hospital with a Respiratory Syncytial Virus-Related Illness.
Study identification
- NCT ID
- NCT02673476
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 9 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 50 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 28, 2016
- Primary completion
- Oct 30, 2016
- Completion
- Oct 30, 2016
- Last update posted
- Feb 3, 2025
2016
United States locations
- U.S. sites
- 11
- U.S. states
- 5
- U.S. cities
- 11
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Lake Internal Med. Assoc. | Eustis | Florida | 32726 | — |
| The Research Center, Inc. | Hialeah | Florida | 33013 | — |
| JDH Medical Group LLC | Miami | Florida | 33186 | — |
| St Lucie Medical Center | Port Saint Lucie | Florida | 34952 | — |
| Tampa Genereal Hospital | Tampa | Florida | 33606 | — |
| Infectious Disease Specialists of Atlanta | Atlanta | Georgia | 30033 | — |
| Kentucky Lung Clinic, PSC | Hazard | Kentucky | 41701 | — |
| Bronson Methodist Hosp. Ped | Kalamazoo | Michigan | 49007 | — |
| William Beaumont Hospital | Troy | Michigan | 48085 | — |
| University of Missouri- Clinical Research Center | Columbia | Missouri | 65212 | — |
| Washington Univ School of Med | St Louis | Missouri | 63110 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 10 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02673476, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 3, 2025 · Synced Sep 6, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02673476 live on ClinicalTrials.gov.